Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 5Recruiting 1Completed 1

Sponsor Class

OTHER 6OTHER_GOV 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 12Lymphoid 7

Conditions

Lymphoma, Non-Hodgkin 3Lymphoma 3Hepatitis B 3Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × entecavir × Lymphoid × Clear all
NCT07493109 2026-03-25

Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP

The First Hospital of Jilin University

Phase 3 Recruiting
200 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04539119 2020-09-04

Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

Ruijin Hospital

Phase 3 Unknown
120 enrolled
Lymphoid

Lymphoma, B-Cell

NCT01765231 2017-01-10

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Peking University

Phase 4 Unknown
190 enrolled
Lymphoid

Hepatitis B, Lymphoma

NCT01768195 2017-01-10

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

Peking University

Phase 4 Unknown
80 enrolled
Lymphoid

Hepatitis B, Lymphoma

NCT00931229 2016-11-09

Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients

National Health Research Institutes, Taiwan

Phase NA Unknown
202 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT01914744 2013-08-02

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

Fudan University

Phase 2 Unknown
82 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00926757 2013-05-29

HBVNHL

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
80 enrolled
Lymphoid

Hepatitis B, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡